Pieris Pharmaceuticals Comprehensive Income 1970-1969 | PVLA
Pieris Pharmaceuticals comprehensive income from 1970 to 1969. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Pieris Pharmaceuticals Annual Comprehensive Income
(Millions of US $) |
Pieris Pharmaceuticals Quarterly Comprehensive Income
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
